Sterling, Virginia-based biotech company Aperiomics has launched a new test that can detect COVID-19.
Founded in 2014, the company uses genomic analysis and machine learning to detect known pathogens from a sample of any nature in just one test. Aperiomics reports that its Xplore-PATHO tech can accurately identify nearly 40,000 microorganisms including over 12,000 clinically relevant pathogens.
Image: An Xplore-COVID-19 testing kit from Aperiomics – Courtesy Photo
{iframe}https://technical.ly/dc/2020/03/20/pathogen-testing-company-aperiomics-has-launched-covid19-test-coronavirus/?utm_campaign=DC%20Editorial%20Email&utm_source=hs_email&utm_medium=email&utm_content=85049359&_hsenc=p2ANqtz–qJeIKz_pHG7ieMMjnE9zJ06aPAtRcgusRHRmIa2q7kWbui-WydG69raH-Tiwsk-CHk_thBivuaYGSuQ0WBndMFfa5RQ&_hsmi=85049359{/iframe}